Poly Medicure: Approves 1,476 Stock Options, Allots 1,975 Equity Shares

Poly Medicure Limited announced the outcome of its Board Meeting held on August 7, 2026. Key decisions included the approval of the Grant of 1,476 Stock Options under the Employee Stock Option Scheme 2020. Additionally, the company approved the Allotment of 1,975 Equity Shares to eligible employees who exercised their options. The company also re-appointed its cost auditors for FY 2026-27 and noted the resignation of its Deputy Company Secretary.

Poly Medicure Board Meeting Highlights Key Decisions

Poly Medicure Limited has announced several significant corporate actions following its Board Meeting on August 7, 2026. The meeting, held at the Jaipur Marriott Hotel, addressed crucial matters pertaining to employee incentives and financial reporting.

Stock Option Initiatives Approved

A key resolution passed was the Grant of 1,476 Stock Options to eligible employees under the Poly Medicure Limited Employee Stock Option Scheme 2020. This initiative is designed to align employee interests with company growth. Subsequently, the company approved the Allotment of 1,975 Equity Shares to employees who exercised their stock options. These shares, each with a face value of ₹5, led to an increase in the company’s paid-up Equity Share Capital to ₹50,68,07,325, comprising 10,13,61,465 equity shares.

Financial Results and Auditory Appointments

The Board also reviewed and approved the Unaudited Financial Results for the first quarter ended June 30, 2026, both on a standalone and consolidated basis. Furthermore, the company announced the Re-appointment of M/s. Jai Prakash & Company as its Cost Auditors for the Financial Year 2026-27.

Leadership Changes Noted

In terms of personnel changes, the Board noted the resignation of Mr. Ravi Prakash from his position as Deputy Company Secretary and Compliance Officer, effective August 10, 2026. His resignation is to pursue alternate career opportunities.

Financial Performance Overview (Q1 FY27)

The unaudited financial results for the quarter ended June 30, 2026, show a standalone revenue from operations of ₹43,109.95 lacs, with a profit after tax of ₹8,812.33 lacs. On a consolidated basis, revenue from operations stood at ₹44,301.49 lacs, with a profit after tax of ₹8,062.17 lacs.

Source: BSE

Previous Article

Mrs. Bector's: Q1 FY27 Investor Presentation Attached

Next Article

Hindalco Industries: Senior Management Role Changes Announced